Shepherd, Finkelman, Miller & Shah, LLP
Shepherd, Finkelman, Miller & Shah, LLP
866-540-5505 877-891-9880

Dedicated Client Advocacy

Products Liability Archives

FDA: Warning letter to Pfizer re EpiPen cites laxity

As revealed in a recent Bloomberg article, there is a stark difference of opinion between health regulators at the U.S Food and Drug Administration and Pfizer, a global pharmaceutical company, regarding one of the latter's product offerings.

Product liability focus: SCOTUS lets lower-court's GM ruling stand

General Motors' executives and shareholders have been decidedly unhappy for over a week now, in the wake of a U.S. Supreme Court action that essentially crushed hopes that the behemoth automaker might escape future liability that could potentially cost the company a flatly astronomical amount of money.

Report: 2016 notably concerning year for defective kids' products

A 12% jump regarding select subject matter relating to America's children can be salutary, indeed, if it is linked with something like collectively improved test scores, an increased immunization rate, lower rates of family-based domestic violence or some other positive development.